BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37460372)

  • 1. Characteristics of pathologic complete response for locally advanced rectal cancer.
    Cloos AJ; Schissel M; Batra R; Donahue SR; Wenos CD; Kumar T; Leinicke JA; Thompson JS; Langenfeld SJ
    Am J Surg; 2023 Dec; 226(6):873-877. PubMed ID: 37460372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 4. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Lutsyk M; Awawda M; Gourevich K; Ben Yosef R
    Am J Clin Oncol; 2021 Sep; 44(9):482-486. PubMed ID: 34269693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic response following treatment for locally advanced rectal cancer: Does location matter?
    Ward WH; Sigurdson ER; Esposito AC; Ruth KJ; Manstein SM; Sorenson EC; Wernick BD; Farma JM
    J Surg Res; 2018 Apr; 224():215-221. PubMed ID: 29506843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation.
    Chow OS; Patil S; Keskin M; Smith JJ; Widmar M; Smith DD; Avila K; Shia J; Chu P; Garcia-Aguilar J
    J Gastrointest Surg; 2019 Apr; 23(4):794-799. PubMed ID: 30719677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study.
    Knight KA; Drami I; McMillan DC; Horgan PG; Park JH; Jenkins JT; Roxburgh CSD
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3409-3420. PubMed ID: 33710416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
    Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
    Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When Should We Expect Curative Results of Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients?
    Georgescu MT; Patrascu T; Serbanescu LG; Anghel RM; Gales LN; Georgescu FT; Mitrica RI; Georgescu DE
    Chirurgia (Bucur); 2021; 116(1):16-23. PubMed ID: 33638322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment.
    Suwanthanma W; Kitudomrat S; Euanorasetr C
    Medicine (Baltimore); 2021 Sep; 100(38):e27366. PubMed ID: 34559161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Role for Routine Restaging After Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Caturegli I; Molin MD; Laird C; Molitoris JK; Bafford AC
    J Surg Res; 2020 Dec; 256():317-327. PubMed ID: 32712447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision.
    Bustamante-Lopez LA; Nahas CSR; Nahas SC; Marques CFS; Pinto RA; Cotti GC; Imperiale AR; de Mello ES; Ribeiro U; Cecconello I
    Int J Surg; 2018 Aug; 56():283-287. PubMed ID: 29981939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 19. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.